Bina Bloggers

Target And Biomarker Identification In PNETs Using NGS Analysis

Posted by Jenny Hsu on Apr 26, 2016 10:00:00 AM

Pancreatic Neuroendocrine Tumors (PNETs) are a rare but clinically important form of cancer. Because many PNETs grow silently and are therefore frequently diagnosed at a late stage, approximately 65% of patients present with unresectable or metastatic disease. As a result, these patients have a poor prognosis and a median survival time of 24 months with limited treatment options.

Read More

Topics: Bina Technologies, Events & Conferences, AAiM, RAVE, Molecular Med, NGS, Tri-Con, Biomarkers, UCSF, Presentation, PNET

Subscribe to Email Updates

Recent Posts

Posts by Topic

see all